
Jehanne Souaya Sitton
Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682, 1655 |
| Total Applications | 1479 |
| Issued Applications | 528 |
| Pending Applications | 307 |
| Abandoned Applications | 653 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13537375
[patent_doc_number] => 20180320234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => BIOMARKERS FOR ASSESSING IDIOPATHIC PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/031384
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/031384 | Biomarkers for assessing idiopathic pulmonary fibrosis | Jul 9, 2018 | Issued |
Array
(
[id] => 17060375
[patent_doc_number] => 11104965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Methods for the diagnosis and treatment of inflammatory bowel disease
[patent_app_type] => utility
[patent_app_number] => 16/028937
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 45
[patent_no_of_words] => 41513
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028937 | Methods for the diagnosis and treatment of inflammatory bowel disease | Jul 5, 2018 | Issued |
Array
(
[id] => 16157365
[patent_doc_number] => 20200216915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => METHOD FOR DETECTING PARASITIC INFECTION AND KIT
[patent_app_type] => utility
[patent_app_number] => 16/628259
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628259 | Method for detecting parasitic infection and kit | Jun 27, 2018 | Issued |
Array
(
[id] => 13479845
[patent_doc_number] => 20180291465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MATERIALS AND METHODS FOR ASSESSMENT OF COLORECTAL ADENOMA
[patent_app_type] => utility
[patent_app_number] => 16/005207
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005207 | MATERIALS AND METHODS FOR ASSESSMENT OF COLORECTAL ADENOMA | Jun 10, 2018 | Abandoned |
Array
(
[id] => 16642435
[patent_doc_number] => 10920276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/991247
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69791
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991247
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/991247 | Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof | May 28, 2018 | Issued |
Array
(
[id] => 13552633
[patent_doc_number] => 20180327864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => C-CBL MUTATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/990301
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990301 | C-CBL mutations and uses thereof | May 24, 2018 | Issued |
Array
(
[id] => 13552631
[patent_doc_number] => 20180327863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => ARID1A AND PPP2R1A MUTATIONS IN CANCER
[patent_app_type] => utility
[patent_app_number] => 15/987235
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987235
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987235 | ARID1A AND PPP2R1A MUTATIONS IN CANCER | May 22, 2018 | Abandoned |
Array
(
[id] => 18748607
[patent_doc_number] => 11807906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Peroxisome biomarkers in HIV disease progression and peroxisome activating drugs for HIV treatment
[patent_app_type] => utility
[patent_app_number] => 16/606665
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 21237
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606665 | Peroxisome biomarkers in HIV disease progression and peroxisome activating drugs for HIV treatment | May 6, 2018 | Issued |
Array
(
[id] => 19274430
[patent_doc_number] => 12024541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Transmembrane pore consisting of two CsgG pores
[patent_app_type] => utility
[patent_app_number] => 16/610895
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 42519
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610895 | Transmembrane pore consisting of two CsgG pores | May 2, 2018 | Issued |
Array
(
[id] => 19274430
[patent_doc_number] => 12024541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Transmembrane pore consisting of two CsgG pores
[patent_app_type] => utility
[patent_app_number] => 16/610895
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 42519
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610895 | Transmembrane pore consisting of two CsgG pores | May 2, 2018 | Issued |
Array
(
[id] => 14019461
[patent_doc_number] => 20190071724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => DIAGNOSTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 15/966905
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15966905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/966905 | DIAGNOSTIC METHODS | Apr 29, 2018 | Abandoned |
Array
(
[id] => 15832589
[patent_doc_number] => 20200131576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis
[patent_app_type] => utility
[patent_app_number] => 16/606928
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606928 | IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis | Apr 23, 2018 | Abandoned |
Array
(
[id] => 13372633
[patent_doc_number] => 20180237857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION
[patent_app_type] => utility
[patent_app_number] => 15/956052
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956052
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956052 | Method of predicting a predisposition to QT prolongation | Apr 17, 2018 | Issued |
Array
(
[id] => 15590477
[patent_doc_number] => 20200071773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => TUMOR SIGNATURE FOR METASTASIS, COMPOSITIONS OF MATTER METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/604651
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604651 | TUMOR SIGNATURE FOR METASTASIS, COMPOSITIONS OF MATTER METHODS OF USE THEREOF | Apr 11, 2018 | Pending |
Array
(
[id] => 15024117
[patent_doc_number] => 20190323063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 15/952133
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952133 | Compositions and methods for detection of | Apr 11, 2018 | Issued |
Array
(
[id] => 13493773
[patent_doc_number] => 20180298429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => BIOCHIPS AND RAPID METHODS FOR DETECTING ORGANISMS INVOLVED IN MICROBIALLY INFLUENCED CORROSION (MIC)
[patent_app_type] => utility
[patent_app_number] => 15/949400
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15949400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/949400 | Biochips and rapid methods for detecting organisms involved in microbially influenced corrosion (MIC) | Apr 9, 2018 | Issued |
Array
(
[id] => 13358007
[patent_doc_number] => 20180230543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => VARIANTS OF TNFSF15 AND DCR3 ASSOCIATED WITH CROHN'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/946632
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946632
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946632 | VARIANTS OF TNFSF15 AND DCR3 ASSOCIATED WITH CROHN'S DISEASE | Apr 4, 2018 | Abandoned |
Array
(
[id] => 13343649
[patent_doc_number] => 20180223364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => TREATING FEMALE PELVIC ORGAN PROLAPSE
[patent_app_type] => utility
[patent_app_number] => 15/944212
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944212 | TREATING FEMALE PELVIC ORGAN PROLAPSE | Apr 2, 2018 | Abandoned |
Array
(
[id] => 18996242
[patent_doc_number] => 11913075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer
[patent_app_type] => utility
[patent_app_number] => 16/499908
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 108
[patent_figures_cnt] => 108
[patent_no_of_words] => 106158
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499908 | Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer | Mar 29, 2018 | Issued |
Array
(
[id] => 13314921
[patent_doc_number] => 20180208997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 15/926861
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926861 | METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS | Mar 19, 2018 | Abandoned |